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However, during these studies, some phosphodiesterase 3 (PDE3) inhibition has been observed in the presence of levosimendan at high concentrations (63) . This side effect also interferes with the inotropic effect mechanisms, since PDE3 inhibition induces an increase in cAMP and a subsequent increase in intracellular calcium concentration. The essential role of calcium in the adequation between energy production and consumption in heart contraction has been recently updated. Predicted by theoretical studies (41, 44, 45) and in vitro experiments (4, 5) , the direct mitochondrial activation by intracellular calcium has been demonstrated for the first time in situ on intact perfused rat heart by using our new integrative approach of heart energetics: modular control analysis (MoCA) (12, 13, 15) .
MoCA is based on the principles of the metabolic control analysis (23, 30, 32) and aimed at the description and quantification of internal regulations in complex biological systems (10, 11, 18, 47) under physiological conditions. The complexity of the system is reduced by grouping reactions and reactants into large modules connected by a small number of intermediates. The fundamental principle is that the kinetic interactions (elasticities) between the intermediates (substrates and products) and the different modules (or single enzymes) determine and maintain steady-state conditions (fluxes and concen-trations). We recently described the first application to intact heart (15) , in which the energetics of contraction is defined as supply and demand modules of the energetic intermediates (PCr, ATP). In perfused beating heart oxidizing pyruvate, the ATP/PCr supply module is almost exclusively mitochondria, whereas the ATP/PCr demand module comprises all the ATPconsuming processes occurring during contraction (mainly myosin ATPase activity and calcium recycling by sarcoplasmic reticulum and cell membrane). MoCA is currently the only approach applicable to intact beating heart that gives information on the quantitative internal controls and regulations of the integrated organ function.
In the present study, MoCA was used to compare the effects of the calcium sensitizer levosimendan with those of epinephrine, a ␤-adrenergic agonist, in paced guinea pigs hearts with the aim to evaluate the respective effects of these compounds on myocardial oxygen consumption (MV O 2 , reflects supply module activity), phosphocreatine concentration ([PCr], energetic intermediate), and contractile activity. MoCA regulation analysis was then carried out to describe qualitatively and quantitatively the relative importance of the two possible routes (i.e., calcium-sensitizing and PDE3 inhibition-cytoplasmic calcium increase) by which levosimendan may exerts its inotropic action.
EXPERIMENTAL PROCEDURES

Heart Perfusion
Male guinea pigs (350 -400 g), fed ad libitum, were anesthetized with 30 mg of pentobarbital sodium, injected intraperitoneally. All the protocols used were approved by the Comité d'éthique regional d'Aquitaine. The corresponding license number is P.D. 3308010 (03/17/1999). The thorax was opened; hearts were rapidly excised, immediately cooled in iced Krebs buffer, and perfused by an aortic canula at constant pressure (80 mmHg) with Krebs-Henseleit solution (95% O 2 and 5% CO2, pH 7.35, temperature 37°C) and using a solution containing (in mM) 108 NaCl, 5.9 KCl, 1.2 MgSO4, 0.5 EDTA, 25 NaHCO3, 10 sodium pyruvate, and 2 CaCl2, as described previously (15, 17) . Left ventricle systolic pressure (LVP) of heart was measured under isovolumic conditions of contraction thanks to a latex balloon inserted in the left ventricle and connected to a pressure transducer (Statham P23Db). Hearts were paced (3-5 V; 150 -200 s, 310 and 320 beats/min) with a stimulator (Thurlsby Thandar Instruments). Dipolar electrodes were placed on the right atrium and on the apex of the heart.
Mechanical performance [heart rate-ventricular pressure product (RPP), in mmHg·beat Ϫ1 ·min Ϫ1 ] was evaluated as the product of heart frequency and LVP. Perfused heart was placed in a 20-mm NMR tube inserted in a 9.4-T superconducting magnet equipped with a 20-mm bore (Bruker DPX400 Avance) for 31 P NMR spectroscopy. When required, specific drugs (see below) were injected using an infusion pump controller (P200; IVAC).
Myocardial Oxygen Consumption
To assess mitochondrial oxidative phosphorylation in paced hearts, MV O2 was measured in hearts perfused under the conditions described above and during injection of levosimendan (0.7 M, n ϭ 6) or epinephrine (0.8 mM, n ϭ 6). After the start of retrograde perfusion, the opening tract of the pulmonary artery was cannulated with a plastic cannula. This cannula was connected to specific tubing that led the perfusate into the oxygen detector. The oxygen probe was connected via a cable to the oxygen monitor (Strathkelvin Instruments, Scotland, UK).
P Nuclear Magnetic Measurements
Pulsed Fourrier-transformed 31 P NMR spectra were obtained using a 9.4-T superconducting magnet with a 9-cm bore. The hearts were inserted into a 1 H/ 31 P double-tuned 20-mm probe. The probe was tuned to the phosphorus resonance frequency of 161.94 MHz, and the magnetic field homogeneity was optimized by shimming on the proton signal coming from the heart and the surrounding medium. The 31 P NMR spectra were obtained without proton decoupling. Pulse width was 23 s (60°pulse angle), recycle time 2 s, and spectral width 5,125 Hz. Partially saturated 31 P NMR spectra were obtained by averaging data from 150 free induction decays (5-min acquisition time). Spectra were analyzed using a 10-Hz exponential multiplication and phased with a zero-order phase correction. Peaks were fitted by Lorentzian function.
Modular Control and Regulation Analyses
The system. The principles of modular control and regulation analyses have been extensively described elsewhere (15, 16) , and only a short description will be found here. In MoCA, complex systems may be simplified by grouping reactions and reactants into large modules connected by a small number of explicit intermediates (10) . We applied this to the study of energy transfer during contraction in heart by defining supply and demand modules linked by energetic intermediates (13, 15, 42) . In working heart, because ATP concentration did not change under physiological conditions of heart activity, PCr was chosen as the representative intermediate between energy supply and demand. The supply module is then defined as all the steps from substrate and oxygen supply to mitochondrial PCr production through the PCr-creatine kinase system (Fig. 1) . The demand module comprises all of the ATP-consuming processes occurring during contraction (myosin ATPases and calcium reuptake by sarcoplasmic reticulum and cell membrane) (15, 16) . Control and regulation of our modular system can be analyzed using MoCA as long as intermediate concentrations and module activities (flux) can be studied. Continuous 31 P NMR spectroscopy gives access to all phosphorylated energetic metabolites, including our intermediate: PCr. The energetic flux through the system was simultaneously assessed as the contractile activity measured RPP (see above).
MoCA. Following the principles of MoCA, control coefficients over the energy flux in heart contraction were calculated from the overall elasticities of the supply and demand modules toward the intermediate PCr (8) . In MoCA, these elasticities are calculated from the changes in flux (RPP) and PCr concentration ([PCr]) induced by a slight modulation of the other module (see Ref. 15 for details). Experimentally, in this study, a low cyanide (KCN) concentration (0.2 Fig. 1 . System definition for modular control analysis of guinea pig heart energetics. We defined the system of contraction as two modules connected by the pool of energetic intermediates. The supply module comprises all the metabolic steps included from substrate supply (including oxygen supply) to mitochondrial production of PCr. The demand module comprises all the steps consuming ATP/PCr linked to contractile activity (contraction of myofilaments and ATP used for calcium recapture). The elasticities of each module toward the intermediates (PCr as representative) are calculated after inducing slight changes in steady-state contraction induced by alteration of the other module. Cyanide (KCN) was chosen to specifically inhibit mitochondrial cytochrome oxidase and measure demand elasticity (εD) as the response of the system to the relative PCr concentration change observed. On the other hand, change in internal balloon pressure was used to increase contractility and measure supply elasticity (εS) (see EXPERIMENTAL PROCEDURES). mM KCN) was used to slightly inhibit mitochondrial cytochrome oxidase to measure demand elasticity (ε PCr D ) from the evolution in contractile activity (RPP) as a function of [PCr] , after a new steady state has been reached. Supply elasticity (ε pcr s ) was measured in the same way, but changes in [PCr] and RPP were induced by increasing internal balloon volume (from 75 to 150 l) to trigger increased heart contractility ( Fig. 1) . The control coefficients of both modules were thus calculated from experimentally measured ε PCr S and ε PCr D according to summation and connectivity theorems (15, 32) . These control coefficients represent how a modification of the activity of a module affects the contractile activity of the heart: the more a module responds to changes in the intermediate PCr (high elasticity), the less this module controls the contraction and therefore the less any modulation of this module will affect contraction. Elasticity and control coefficients allow the complete description of the control pattern of the energetics of heart contraction under the conditions studied. In the present study, both experimental modulations of PCr concentration by the increase in balloon pressure and low KCN infusion were carried out on every paced guinea pig heart.
Regulation analysis. Once the control pattern of the system has been described, regulation analysis may be applied to the action of an external effector (15) . Levosimendan, the (Ϫ)enantiomer of (R)-{[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)-phenyl]hydrazono}propanedinitrile synthesized by Abbot Scandinavia (Solna, Sweden), has been tested at a circulating concentration of 0.7 M (34), which also triggered the optimal inotropic response on perfused guinea pig hearts under our conditions (results not shown).
Regulation analysis has the potential to provide a quantitative description of how an effector modifies heart contractile activity, both globally and internally by describing its effect on each module of the system. Experimentally, this analysis requires the complete elasticities and control coefficient measurements under the control conditions (in the absence of the effector, see above) as well as the measurements of the effects of 0.7 M levosimendan on metabolites (PCr) and energy flux (contractile activity, RPP). The response of paced heart to levosimendan was then calculated using the principles of top-down analysis established by Ainscow and Brand (2) and recently applied by us on perfused rat heart (15) . The effects of levosimendan were quantified in terms of indirect effect (quantify the internal effects due to PCr changes) and direct effect (quantify the direct effect of levosimendan) on each module. Finally, this approach allows us to know how levosimendan acts on the entire perfused heart through each module (Global Response) (15) .
Statistics
Experimental values are reported as means Ϯ SD for n independent guinea pigs hearts. The error associated with calculated indirect, direct, and global effects was determined by using Monte Carlo simulations (1) . Experimental values of ⌬PCr/PCr and ⌬RPP/RPP were simulated from observed means and SDs. Simulations were based on a normal distribution with a mean equal to the mean of the experimental points and an SD equal to the SD of the experimental points.
RESULTS
Modular Control Analysis
The first step in the analysis is the determination of the kinetic parameters (the elasticities; see EXPERIMENTAL PROCEDURES) of energy supply and demand module interactions with the energetic (phosphorylated) intermediates, represented by [PCr] (see EX-PERIMENTAL PROCEDURES and Fig. 1) (15) . Therefore, MoCA requires the experimental determination on intact heart of the response of each module to small changes in the intermediate (PCr). These changes should be provoked artificially by specifically inhibiting or activating every module and studying the other (untouched) module's response (see Fig. 1 ) (15) . In the present study, determination of supply response to PCr changes was obtained by increasing cardiac activity by the FrankStarling effect (increase in myofilament calcium sensitivity) (3, 31, 36, 59) . We previously showed that identical elasticities were obtained by inhibition of myofilament ATPase activity by 2,3-butanedione monoxime (BDM) (42, 43) . It has been shown that rapid increase in twitch force after cardiac muscle stretch was not associated with a rise in calcium transient (38, 49) or a modification of calcium recirculation (51) . Therefore, as with BDM, increasing the volume of the balloon inserted in the left ventricle caused a change in contractile activity (demand) in the absence of calcium change that may potentially affect mitochondrial activity (supply) (28, 37, 50, 60) .
The increase in balloon pressure induced a small but significant decrease in [PCr] (Table 1 ) and a concomitant increase in heart contractile activity (RPP), which reflects the response (elasticity) of supply (mitochondria) to the induced change in PCr. Similarly, to determine demand elasticity, KCN (a specific mitochondrial inhibitor) was used to inhibit supply. A low KCN concentration (0.2 mM) was chosen to only induce small changes in PCr, without any change in ATP (Table 1) , sufficient to induce a measurable decrease in contractile activity (Table 1) .
Results presented in Table 1 allowed the calculation of elasticities and flux (contraction) control coefficients of paced perfused guinea pig hearts under our experimental conditions. The values of the elasticities measured show that supply (ε PCr S ϭ Ϫ6.15 Ϯ 5.42; the minus sign of ε PCr S indicates that a decrease in PCr activates mitochondria) was much more responsive to small changes in PCr than contractile processes (demand: ε PCr D ϭ 0.85 Ϯ 0.2). The distribution of the control of contraction energetics directly derives from these elasticities. The results presented in Table 2 show that, under our conditions, most of the control on contraction is on the demand module (ϳ88%), indicating that myofibrils mostly determine heart activity. These values of flux control coefficients are similar to those observed in perfused rat hearts where the demand module takes up to 95% of the control under similar conditions (15) . (RPP) by 44.8 Ϯ 18.3%. Because the experiments were carried out on paced hearts, the increase of contractile activity is totally explained by the increase of the developed LVP. Figure 2 presents the changes in the energetic intermediates of guinea pig perfused heart induced by the infusion of 0.7 M levosimendan, assessed by 31 P NMR spectrometry. When pyruvate was used as substrate, inorganic phosphate (P i ) was undetectable, by contrast with glucose utilization (15, 16, 22) . No change in ATP concentration (Ͻ1%) was observed following levosimendan infusion, and only a small but significant decrease in PCr concentration (ϳ7%) could be measured. 31 P NMR measurements also allowed the calculation of the changes in phosphate potential (⌬Gp) and showed that ⌬Gp was modified by Ͻ1% in the presence of levosimendan, according to previous observations (22) . The effect of 0.8 g/l epinephrine on perfused guinea pig heart is also presented in Table 3 for comparison. The contractile activity is almost doubled in the presence of epinephrine, but without any decrease in PCr concentration. This last result demonstrates that the decrease in [PCr] after levosimendan infusion is not due to inadequate oxygen supply.
Regulation Analysis of the Inotropic Effect of Levosimendan
Together with MoCA analysis, the above results allow the application of regulation analysis to the effect of levosimendan on perfused guinea pig heart to describe quantitatively the direct effect of this drug on supply and demand modules (Fig. 3) . First, the indirect effects (supply activation by 40% and demand inhibition by Ϫ5.5%) were calculated as the product of the relative PCr change induced by levosimendan (see Table 3 ) and the previously measured elasticities of each module toward PCr (Table 2 ) (see EXPERIMENTAL PROCEDURES for details). The direct effects of levosimendan on each module could thus be calculated as the difference between the total effect observed on contraction and these indirect effects due to PCr change calculated above. Values are presented in Fig. 3 and clearly show that levosimendan had almost no direct effect on mitochondrial activity (ϳ5.1%, not significant) and that the only direct effect measured is an activation of myofibril activity by 50.7%.
The last information obtained from the regulation analysis is the quantification of the global response of heart contraction to levosimendan through each module, i.e., how strongly the effector acts on the system through each route (9) . Figure 3 shows that the overall effect of levosimendan on heart contraction is entirely due to myofilament activation (44.5%), and no effect occurs through mitochondria (0.6%). In the absence of direct effect of levosimendan on mitochondria, contraction energetics is only sustained by the indirect mitochondrial activation (40%) induced by the relatively small but significant drop in [PCr] .
Effect of Levosimendan and Epinephrine on Heart Oxygen Consumption
Because energy supply is almost entirely sustained by mitochondrial oxidative phosphorylation, MV O 2 represents supply module activity. Oxygen consumption measurements showed that supply module activity was slightly increased following the addition of levosimendan (14 Ϯ 10%; n ϭ 6). This change in MV O 2 was significantly much lower than during epinephrine perfusion (Table 3) . Indeed, the ratio ⌬MV O 2 vs. ⌬RPP [representative of mechanical efficiency (34, 55)] was 0.18 Ϯ 0.13 in the levosimendan group compared with 0.93 Ϯ 0.38 in the epinephrine group (P Ͻ 0.001).
DISCUSSION
In the present study, we applied our in situ MoCA of perfused heart energetics to describe the relative importance of the different routes of the inotropic effect of levosimendan on the heart (61). Besides pure calcium-sensitizing effects, in vivo and at high concentration, levosimendan also leads to some phosphodiesterase inhibition (29) , as well as vasodilatory effect (35) and vasodilatation through the opening of ATP-sensitive potassium channels in cell membrane and mitochondria (40) . Recently applied to intact heart, MoCA was used to demonstrate for the first time the direct mitochondrial activation by cytosolic calcium during contraction (15, 16) . Indeed, MoCA is currently the only approach applicable to an intact beating heart that gives quantitative information on the internal controls and regulations as well as deregulations of integrated organ function. Moreover, MoCA has the potential to describe how the system moves from one steady state to another in response to a drug (epinephrine) (42) or a dysfunction (chronic hypoxia) (12, 13) .
First, in the present study, MoCA of perfused paced guinea pig hearts indicated that control of contraction resided mainly on myofibrils (demand) (88 vs. 12% for supply). This control pattern is the result of the high reactivity (the elasticity) of supply (mainly mitochondria) to changes in PCr. These results indicate that, under our conditions, heart contractility is almost totally controlled by Values are means Ϯ SD. Significant differences between supply and demand: *P Ͻ 0.05 and †P Ͻ 0.01. Fig. 2 . Kinetic recording of 31 P NMR spectra of guinea pig heart illustrating the effect of 0.7 M levosimendan addition to the perfusate. PME, phosphomonoesters; PCr, phosphocreatine. The arrow indicates the addition of 0.7 M levosimendan to the perfusion medium. myofibril activation and only slightly by mitochondrial oxidative phosphorylation, oxygen, or substrate availability.
Levosimendan triggers an inotropic effect on paced guinea pig hearts, characterized by a 45% increase of contractile activity, totally explained by an increase in LVP. Results obtained from 31 P NMR spectroscopy of these hearts highlighted a concomitant significant decrease in PCr concentration (7%) induced by levosimendan, but without any change in inorganic phosphate or ATP concentrations and therefore no significant change in phosphorylation potential (⌬Gp). Therefore levosimendan does not cause alteration of cellular energetics in beating heart. To be certain to obtain the maximal effect of levosimendan on oxygen consumption and PDE3 inhibition, we used a concentration of 0.7 M in our model, which is higher than the EC 50 described in the literature (25) . In fact, 0.7 M is 20-fold higher than the EC 50 of levosimendan as inotrope in isolated Langendorf perfused guinea pig hearts (34), 100-fold higher than the EC 50 value of its direct inotropic action on isolated demembranated cardiac contractile fibers (63) , and 1,000-fold higher its in vitro IC 50 on PDE3 enzymes (33) . Moreover, at low concentrations, levosimendan would induce inotropic effects without increasing any calcium transients in opposite to higher nontherapeutic doses that could induce changes in calcium (19, 27, 34) .
MoCA regulation analysis was used here to describe the integrated effects of levosimendan leading to heart activation, and the direct effects of levosimendan on each module (supply and demand) could be calculated (see Fig. 3 ). Our results evidenced a very small direct effect of levosimendan on supply module (ϳ5%) compared with the 50% direct activation of demand. This slight activation of supply may be correlated to the inhibition of PDE3 activity and/or rise in cAMP and the corresponding rise in cytosolic calcium by levosimendan previously shown in skinned fiber experiments (26) . Indeed, any significant increase in intracellular calcium would activate mitochondrial oxidative phosphorylation (28, 37, 50, 60) , and this would be revealed by MoCA analysis. Our results suggest that some inhibition of PDE3 may arise after levosimendan injection to paced guinea pig hearts but is too small to induce significant mitochondrial activation. This is further evidenced by the measured global effect on heart contraction through this mitochondrial activation, which is below 1%, due to the low control by supply on contraction, while the global effect through demand is ϳ45%.
MoCA regulation analysis described the response of energy supply after levosimendan activation without any direct effect on this module (see above). MoCA analysis presented here allows describing how the decrease in PCr, and the corresponding increase in free creatine, activates mitochondrial oxidative phosphorylation and sustains ATP/PCr production necessary for contraction. Regulation analysis illustrates this through the indirect effect of levosimendan on both modules via PCr concentration change. Because of the high elasticity of the supply module to PCr changes, the consequence of only 7% PCr decrease is a 40% increase in mitochondrial activity. By contrast, demand elasticity is low and PCr decrease has a negligible (Ϫ5.5%) indirect effect.
Previous studies have shown the correlation between a rise in cytosolic calcium concentration and an increase in heart oxygen consumption (39, 65) . By comparing the changes in oxygen consumption by hearts submitted to levosimendan or epinephrine (Table 3) , we demonstrated here that a much lower change in MV O 2 was measured with levosimendan for the same increase in RPP. This result confirms that levosimendan causes a positive inotropic effect in the absence of a significant increase in cytosolic calcium concentration (6, 22, 26, 29, 46) . On the contrary, the increase in MV O 2 observed after epinephrine addition is perfectly Values are means Ϯ SD; n ϭ 6 hearts in each group. MV O 2 , myocardial oxygen consumption; ⌬P, change in pressure. Brackets denote concentration. ND, not determined. *P Ͻ 0.05 and †P Ͻ 0.001 between levosimendan or epinephrine addition and control. ‡P Ͻ 0.05 and §P Ͻ 0.001 between levosimendan and epinephrine. Fig. 3 . Modular control analysis of the effects of 0.7 M levosimendan addition in the perfusion medium on perfused guinea pig heart bioenergetics. Levosimendan effects on both supply and demand modules were calculated as described under EXPERIMENTAL PROCEDURES: direct effect refers to the integrated elasticity (total effect Ϫ indirect effect) and global response to the response coefficient of each module on the increase in contraction induced by calcium increase. The size of the arrows is proportional to levosimendan effect and the nos. represent the effect expressed as %change from control conditions. Actual values (%) Ϯ error (calculated from Monte-Carlo simulations -500 simulations) for supply and demand modules, respectively: direct effect 5.1 Ϯ 1.7 and 50.7 Ϯ 1.9, global effect 0.6 Ϯ 0.1 and 44.5 Ϯ 3.1, indirect effect 40.0 Ϯ 2.6 and Ϫ5.5 Ϯ 0.7.
explained by an elevated calcium concentration. Indeed, epinephrine stimulates directly the supply module, in accordance with the "parallel activation" mechanism of heart contraction by calcium (7, 15, 42) . Consequently, although the inotropic effects of levosimendan and epinephrine were similar, the activation of heart contraction by levosimendan occurs with a higher energetic efficiency (29, 34, 46, 55) . Indeed, it is now well established on isolated mitochondria that the increase in oxidative phosphorylation in response to the activation of ATP synthase activity (higher ATP demand) occurs at the expense of mitochondrial membrane potential, with the direct consequence of an inhibition of proton leakage, highly dependent on membrane potential and phosphorylation activity (9, 52) . Therefore, in the presence of levosimendan, both the absence of a significant calcium increase and the decrease in PCr are responsible for the activation of oxidative phosphorylation and ATP production without a marked increase in oxygen consumption. These conclusions represent a lead to understanding the increase in myocardial efficiency observed during levosimendan infusion to isolated perfused hearts (22, 34) or patients (64, see Ref. 53 for review). Levosimendan therefore appears as a very valuable drug against cardiac insufficiency by helping the heart to respond to increased contractile activity with limiting increase in oxygen requirement.
Perspectives and Significance
The results presented in this paper show that MoCA may be helpful for elucidating the physiological mechanisms of cardiac excitation-contraction coupling as well as the modifications triggered by drugs. This first application to the effect of a drug illustrates the possible use for the discrimination of physiologically relevant effects on the integrated function of intact beating heart.
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